Clinical Trials · NCT06632444
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
- Phase
- Phase 3
- Recruitment status
- Recruiting
- Sponsor
- Boehringer Ingelheim
- Enrollment
- 1,800
- Start date
- Sep 2024
- Locations
- 525 sites, 36 countries
- Primary endpoint
- Part 1: Resolution of MASH without worsening of liver fibrosis on MASH Clinical Research Network (CRN) fibrosis score